The WVU Cancer Institute welcomes Mike Ridinger, R.N., M.B.A., as assistant director of finance and administration and the administrator of Hematology/Oncology.
Ridinger is a graduate from Seton Hall University with over fifteen years of experience within the health and medical systems. His background includes understanding and utilizing economic, financial, market, and industry segment data to identify key issues and implications for potential strategies and plans.
Ridinger has experience implementing strategic imperatives within academic and private healthcare environments in order to lead and drive change. He has an in-depth knowledge of market forces and the ability to function in highly competitive markets and the ability to build lasting relationships with internal and external strategic partners.
“Mike's extensive experience, overall vision and clinical expertise will help to guide the growth of the section of hematology/oncology,” Richard Funnell, vice president of cancer services, said.
“This experience will be of great service to our physicians and patients as we continue to grow the WVU Cancer Institute,“ Richard Goldberg, M.D., director of the WVU Cancer Institute, said. "He brings with him a wealth of experiences that will help us to develop our programs."
As assistant director of finance and administration and the administrator of Hematology/Oncology, Ridinger’s primary function will be to support Hematology and Oncology faculty, mid-level providers, and oversee WVU Medicine, University Healthcare Associates, Foundation, and WVU Research Corporation budgets for the WVU Cancer Institute and the section of Hematology/Oncology.
Employees of WVU Medicine and the WVU Cancer Institute came together on Monday, May 20 to join organizations across the world in celebrating Clinical Trials Day on May 20. This day recognizes those who conduct clinical trials, raises awareness of clinical trials and clinical research, and is an opportunity to show gratitude for the work they do to improve public health.
What started with a small gift between friends has now evolved into the larger “gift of humanity.” Lemons of Love was started in 2014 after the founder, Jill Swanson Peltier, was diagnosed with Stage III Colon Cancer. Jill had received a small goodie bag from a friend with a few items that were meant to help her through her chemotherapy treatment. Touched by the kindness and thoughtfulness of this gift, she knew that this was something that everyone starting their battle with cancer should receive. Jill envisioned being able to give others the same support that she received, in the form of a simple gift that makes a big impact.
WVU Cell & Molecular Biology and Biomedical Engineering Training Program (CBTP)